Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study to Collect Real-world Effectiveness, Safety, and Adherence Data on Extended-release Calcifediol (Rayaldee®) in Non-dialysis CKD Patients With Secondary Hyperparathyroidism. Protocol Version 2.0, 06DEC2023

NCT05460234 is registered in ClinicalTrials.gov with Vifor (International) Inc. as lead sponsor.

NCT NCT05460234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05460234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study to Collect Real-world Effectiveness, Safety, and Adherence Data on Extended-release Calcifediol (Rayaldee®) in Non-dialysis CKD Patients With Secondary Hyperparathyroidism. Protocol Version 2.0, 06DEC2023
Lead sponsor
Vifor (International) Inc.
Phase
Observational
Overall status
Completed
Start date
October 5, 2022
Completion date
June 30, 2025
Enrollment
110 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease